267 related articles for article (PubMed ID: 38014097)
1. Macrophage Depletion Protects Against Cisplatin-Induced Ototoxicity and Nephrotoxicity.
Sung CYW; Hayase N; Yuen PST; Lee J; Fernandez K; Hu X; Cheng H; Star RA; Warchol ME; Cunningham LL
bioRxiv; 2023 Nov; ():. PubMed ID: 38014097
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan ameliorates cisplatin-induced ototoxicity: Rat model.
Gozeler MS; Ekinci Akdemir FN; Yildirim S; Sahin A; Eser G; Askin S
Int J Pediatr Otorhinolaryngol; 2019 Jul; 122():70-75. PubMed ID: 30978472
[TBL] [Abstract][Full Text] [Related]
3. Ototoxicity: a high risk to auditory function that needs to be monitored in drug development.
Pasdelou MP; Byelyayeva L; Malmström S; Pucheu S; Peytavy M; Laullier H; Hodges DB; Tzafriri AR; Naert G
Front Mol Neurosci; 2024; 17():1379743. PubMed ID: 38756707
[TBL] [Abstract][Full Text] [Related]
4. Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice.
Li Y; Ding D; Jiang H; Fu Y; Salvi R
Neurotox Res; 2011 Nov; 20(4):307-19. PubMed ID: 21455790
[TBL] [Abstract][Full Text] [Related]
5. Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.
Ciarimboli G; Deuster D; Knief A; Sperling M; Holtkamp M; Edemir B; Pavenstädt H; Lanvers-Kaminsky C; am Zehnhoff-Dinnesen A; Schinkel AH; Koepsell H; Jürgens H; Schlatter E
Am J Pathol; 2010 Mar; 176(3):1169-80. PubMed ID: 20110413
[TBL] [Abstract][Full Text] [Related]
6. [Experimental studies of the protective effect of deferoxamine mesilate on cisplatin induced toxicity].
Watanabe H; Kanno H
Nihon Jibiinkoka Gakkai Kaiho; 1998 Aug; 101(8):967-78. PubMed ID: 9778942
[TBL] [Abstract][Full Text] [Related]
7. An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity.
Fernandez K; Wafa T; Fitzgerald TS; Cunningham LL
Hear Res; 2019 Apr; 375():66-74. PubMed ID: 30827780
[TBL] [Abstract][Full Text] [Related]
8. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
9. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
10. Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice.
Schmitt NC; Rubel EW
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):614-20. PubMed ID: 23884286
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.
Hill GW; Morest DK; Parham K
Otol Neurotol; 2008 Oct; 29(7):1005-11. PubMed ID: 18716567
[TBL] [Abstract][Full Text] [Related]
12. Effect of high-dose cisplatin on auditory brainstem responses and otoacoustic emissions in laboratory animals.
Sockalingam R; Freeman S; Cherny TL; Sohmer H
Am J Otol; 2000 Jul; 21(4):521-7. PubMed ID: 10912698
[TBL] [Abstract][Full Text] [Related]
13. Transient Receptor Potential Channels and Auditory Functions.
Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
[No Abstract] [Full Text] [Related]
14. Effect of cisplatin chemotherapy on the inner ear function and serum prestin concentration.
Jalali MM; Saedi HS; Saadat F
Eur Arch Otorhinolaryngol; 2022 Jun; 279(6):2783-2789. PubMed ID: 34213608
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein-mediated protection against Cisplatin-induced hair cell death.
Baker TG; Roy S; Brandon CS; Kramarenko IK; Francis SP; Taleb M; Marshall KM; Schwendener R; Lee FS; Cunningham LL
J Assoc Res Otolaryngol; 2015 Feb; 16(1):67-80. PubMed ID: 25261194
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment with annexin A1-derived peptide protects against cisplatin-induced hearing loss.
Sena LS; Sasso GRS; Sanches JM; Franco PC; Azevedo MF; Oliani SM; Gil CD
Toxicol Lett; 2022 Jun; 363():27-35. PubMed ID: 35561849
[TBL] [Abstract][Full Text] [Related]
17. Protective roles of fenofibrate against cisplatin-induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction.
Kim SJ; Park C; Lee JN; Park R
Toxicol Appl Pharmacol; 2018 Aug; 353():43-54. PubMed ID: 29908243
[TBL] [Abstract][Full Text] [Related]
18. PD-1 Inhibition Minimally Affects Cisplatin-Induced Toxicities in a Murine Model.
Spielbauer K; Cunningham L; Schmitt N
Otolaryngol Head Neck Surg; 2018 Aug; 159(2):343-346. PubMed ID: 29609517
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of Ginkgo biloba extract against experimental cisplatin ototoxicity: animal research using distortion product otoacoustic emissions.
Cakil B; Basar FS; Atmaca S; Cengel SK; Tekat A; Tanyeri Y
J Laryngol Otol; 2012 Nov; 126(11):1097-101. PubMed ID: 22975015
[TBL] [Abstract][Full Text] [Related]
20. The effects of ethyl pyruvate against experimentally induced cisplatin ototoxicity in rats.
Ayral M; Toprak SF
Somatosens Mot Res; 2021 Dec; 38(4):347-352. PubMed ID: 34635013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
